Revance Therapeutics, Inc.
RVNC · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$324 | -$356 | -$281 | -$282 |
| Dep. & Amort. | $14 | $39 | $20 | $10 |
| Deferred Tax | $0 | $0 | $0 | -$3 |
| Stock-Based Comp. | $48 | $52 | $43 | $36 |
| Change in WC | -$44 | $1 | -$5 | $40 |
| Other Non-Cash | $90 | $71 | $1 | $20 |
| Operating Cash Flow | -$217 | -$194 | -$222 | -$179 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$23 | -$18 | -$4 |
| Net Acquisitions | $0 | $20 | $8 | -$1 |
| Inv. Purchases | -$264 | -$348 | -$184 | -$259 |
| Inv. Sales/Matur. | $385 | $232 | $172 | $276 |
| Other Inv. Act. | -$5 | -$20 | -$8 | $17 |
| Investing Cash Flow | $110 | -$139 | -$30 | $12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30 | $87 | $0 | $288 |
| Stock Issued | $100 | $248 | $22 | $84 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | -$3 | $8 | -$40 |
| Financing Cash Flow | $137 | $332 | $30 | $331 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30 | -$1 | -$221 | $165 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $115 | $116 | $337 | $172 |
| End Cash | $145 | $115 | $116 | $337 |
| Free Cash Flow | -$223 | -$217 | -$240 | -$183 |